This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) And Somaxon Pharmaceuticals (SOMX)





NEW YORK, Dec. 18, 2012 /PRNewswire/ --

Young Innovations, Inc.

Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded above the offer price as recently as September 27, 2012.

Click here to learn more about the investigation: http://zlk.9nl.com/young-innovations-ydnt/ , or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Compuware Corp.

Levi & Korsinsky is investigating the Board of Directors of Compuware Corp. (NasdaqGS: CPWR) for possible breaches of fiduciary duty and other violations of state law in connection with a going private proposal from Elliott Management Corp. ("Elliott") under which Elliott would acquire the outstanding shares of Compuware it does not currently own for a value of $11 per share.  At least one analyst set a price target for Compuware stock at $12.00 per share.

Click here to learn how to join the action: http://zlk.9nl.com/compuware-cpwr/ , or call: 877-363-5972.

Caribou Coffee Co. Inc.

Levi & Korsinsky is investigating the Board of Directors of Caribou Coffee Co. Inc. (Nasdaq: CBOU) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Joh. A. Benckiser Group for $16 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/caribou-coffee-cbou/ , or call: 877-363-5972.

Somaxon Pharmaceuticals

Levi & Korsinsky is investigating the Board of Directors of Somaxon Pharmaceuticals, Inc. (NasdaqCM: SOMX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX).

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,980.54 -103.26 -0.60%
S&P 500 1,983.19 -4.79 -0.24%
NASDAQ 4,448.4050 -23.7030 -0.53%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs